Literature DB >> 19725250

Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.

Thomas C Thannickal1, Robert Nienhuis, Jerome M Siegel.   

Abstract

STUDY
OBJECTIVES: Narcolepsy with cataplexy is characterized by a loss of approximately 90% of hypocretin (Hcrt) neurons. However, more than a quarter of narcoleptics do not have cataplexy and have normal levels of hypocretin in their cerebrospinal fluid, raising the possibility that their disease is caused by unrelated abnormalities. In this study we examined hypocretin pathology in narcolepsy without cataplexy.
DESIGN: We examined postmortem brain samples, including the hypothalamus of 5 narcolepsy with cataplexy patients; one narcolepsy without cataplexy patient whose complete hypothalamus was available (patient 1); one narcolepsy without cataplexy patient with anterior hypothalamus available (patient 2); and 6 normal brains. The hypothalamic tissue was immunostained for Hcrt-1, melanin-concentrating hormone (MCH), and glial fibrillary acidic protein (GFAP). MEASUREMENTS AND
RESULTS: Neither of the narcolepsy without cataplexy patients had a loss of Hcrt axons in the anterior hypothalamus. The narcolepsy without cataplexy patient whose entire brain was available for study had an overall loss of 33% of hypocretin cells compared to normals, with maximal cell loss in the posterior hypothalamus. We found elevated levels of gliosis with GFAP staining, with levels increased in the posterior hypothalamic nucleus by (295%), paraventricular (211%), periventricular (123%), arcuate (126%), and lateral (72%) hypothalamic nuclei, but not in the anterior, dorsomedial, or dorsal hypothalamus. There was no reduction in the number of MCH neurons in either patient.
CONCLUSIONS: Narcolepsy without cataplexy can be caused by a partial loss of hypocretin cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19725250      PMCID: PMC2717206          DOI: 10.1093/sleep/32.8.993

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  18 in total

1.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

2.  The nucleator.

Authors:  H J Gundersen
Journal:  J Microsc       Date:  1988-07       Impact factor: 1.758

3.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.

Authors:  C Peyron; J Faraco; W Rogers; B Ripley; S Overeem; Y Charnay; S Nevsimalova; M Aldrich; D Reynolds; R Albin; R Li; M Hungs; M Pedrazzoli; M Padigaru; M Kucherlapati; J Fan; R Maki; G J Lammers; C Bouras; R Kucherlapati; S Nishino; E Mignot
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

4.  Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat.

Authors:  D Gerashchenko; M D Kohls; M Greco; N S Waleh; R Salin-Pascual; T S Kilduff; D A Lappi; P J Shiromani
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

5.  Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.

Authors:  Yasunori Oka; Yuichi Inoue; Takashi Kanbayashi; Kenji Kuroda; Masayuki Miyamoto; Tomoyuki Miyamoto; Akio Ikeda; Tetsuo Shimizu; Yasuo Hishikawa; Hiroshi Shibasaki
Journal:  Sleep       Date:  2006-11       Impact factor: 5.849

6.  Relationship between CSF hypocretin levels and hypocretin neuronal loss.

Authors:  Dmitry Gerashchenko; Eric Murillo-Rodriguez; Ling Lin; Man Xu; Laura Hallett; Seiji Nishino; Emmanuel Mignot; Priyattam J Shiromani
Journal:  Exp Neurol       Date:  2003-12       Impact factor: 5.330

7.  Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy.

Authors:  Thomas C Thannickal; Jerome M Siegel; Robert Nienhuis; Robert Y Moore
Journal:  Brain Pathol       Date:  2003-07       Impact factor: 6.508

8.  Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1).

Authors:  Paul Christian Baier; Sara Lena Weinhold; Verena Huth; Birgit Gottwald; Roman Ferstl; Dunja Hinze-Selch
Journal:  Brain       Date:  2008-08-21       Impact factor: 13.501

9.  Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.

Authors:  A M Blouin; T C Thannickal; P F Worley; J M Baraban; I M Reti; J M Siegel
Journal:  Neurology       Date:  2005-08-31       Impact factor: 9.910

10.  Reduced number of hypocretin neurons in human narcolepsy.

Authors:  T C Thannickal; R Y Moore; R Nienhuis; L Ramanathan; S Gulyani; M Aldrich; M Cornford; J M Siegel
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

View more
  65 in total

Review 1.  Orexin receptors: pharmacology and therapeutic opportunities.

Authors:  Thomas E Scammell; Christopher J Winrow
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

Review 2.  Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity.

Authors:  Angie M Cason; Rachel J Smith; Pouya Tahsili-Fahadan; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Physiol Behav       Date:  2010-03-23

3.  Orexin neurons use endocannabinoids to break obesity-induced inhibition.

Authors:  Alán Alpár; Tibor Harkany
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-29       Impact factor: 11.205

4.  Sleep dynamics beyond traditional sleep macrostructure.

Authors:  Giuseppe Plazzi; Fabio Pizza
Journal:  Sleep       Date:  2013-08-01       Impact factor: 5.849

5.  Narcolepsy and streptococcal infections.

Authors:  W T Longstreth; Thanh G N Ton; Thomas D Koepsell
Journal:  Sleep       Date:  2009-12       Impact factor: 5.849

6.  [Narcolepsy].

Authors:  G Mayer
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

7.  Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulation.

Authors:  Jasbir Dalal; Jee Hoon Roh; Susan E Maloney; Afua Akuffo; Samir Shah; Han Yuan; Brie Wamsley; Wendell B Jones; Cristina de Guzman Strong; Paul A Gray; David M Holtzman; Nathaniel Heintz; Joseph D Dougherty
Journal:  Genes Dev       Date:  2013-02-21       Impact factor: 11.361

Review 8.  Genetic association, seasonal infections and autoimmune basis of narcolepsy.

Authors:  Abinav Kumar Singh; Josh Mahlios; Emmanuel Mignot
Journal:  J Autoimmun       Date:  2013-03-13       Impact factor: 7.094

Review 9.  Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction.

Authors:  Coleman B Calva; Jim R Fadel
Journal:  Brain Res       Date:  2018-08-24       Impact factor: 3.252

10.  Increased immune complexes of hypocretin autoantibodies in narcolepsy.

Authors:  Aude Deloumeau; Sophie Bayard; Quentin Coquerel; Pierre Déchelotte; Christine Bole-Feysot; Bertrand Carlander; Valérie Cochen De Cock; Sergueï O Fetissov; Yves Dauvilliers
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.